Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer
BACKGROUND: Prostate cancers exhibit intratumor heterogeneity (ITH), like other cancer types. The ITH may affect diverse phenotypes such as treatment response, drug resistance, and clinical outcomes. It is crucial to consider ITH to understand tumorigenesis. METHODS: Genomic and transcriptomic profi...
Main Authors: | Jae Won Yun, Soomin Lee, Daeun Ryu, Semi Park, Woong-Yang Park, Je-Gun Joung, Jeongyun Jeong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523318303541 |
Similar Items
-
Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid Tumors
by: Boram Lee, et al.
Published: (2018-12-01) -
Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
by: Ji-Yong Sung, et al.
Published: (2019-01-01) -
Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity
by: Ji-Yong Sung, et al.
Published: (2020-08-01) -
Genomic Characterization and Comparison of Multi-Regional and Pooled Tumor Biopsy Specimens.
by: Je-Gun Joung, et al.
Published: (2016-01-01) -
Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
by: Jun Seok Kim, et al.
Published: (2015-04-01)